Co-amplification of erbB2, topoisomerase II α and retinoic acid receptor α genes in breast cancer and allelic loss at topoisomerase I on chromosome 20
W. Nicol Keith(University of Glasgow), Robert Brown(Emerson College), Stuart Kaye(University of Wollongong), H. McCallum(Glasgow Victoria Infirmary), Fiona Douglas(University of Southern California), W.D. George(Western Infirmary), Gordon Wishart(Anglia Ruskin University)
Cited by 72
Related Papers
Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma
|The American Journal of Human Genetics|2001|1.1k
International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers
|UCL Discovery (University College London)|1997|1k
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
|JNCI Journal of the National Cancer Institute|2013|946
Germline <i>BRCA</i> Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
|Journal of Clinical Oncology|2013|833
Germline mutations in RAD51D confer susceptibility to ovarian cancer
|Nature Genetics|2011|545